bleomycin - CISMeF

Preferred Label : bleomycin;

MeSH definition : A complex of related glycopeptide antibiotics from Streptomyces verticillus consisting of bleomycin A2 and B2. It inhibits DNA metabolism and is used as an antineoplastic, especially for solid tumors.;

MeSH synonym : bleomycins;

CISMeF synonym : Bristol-Myers squibb brand of bleomycin sulfate; almirall brand of bleomycin sulfate; bellon brand of bleomycin sulfate; bristol myers squibb brand of bleomycin sulfate; bull brand of bleomycin sulfate; cell pharm brand of bleomycin sulfate; lemery brand of bleomycin sulfate; mack brand of bleomycin sulfate;

DeCS synonym : Bl omycine Bellon;

MeSH hyponym : bleolem; lundbeck brand of bleomycin sulfate; BLEO-cell; bleomycinum mack; bleomycin A2; bléomycine bellon; bleomicina; blenoxane; bleomycin B2; bleomycin sulfate; BLEO cell; BLEOcell; Bellon, Bléomycine; Bleomycin A(2); Bleomycin B(2); Sulfate, Bleomycin; Mack, Bleomycinum; Blanoxan;

MeSH Related Number : bleomycin sulfate; 9041-93-4 (sulfate (salt)); bleomycin B2; bleomycin A2; 13M89UEA7W; M62KK37O40;

Registry Number MeSH : 11056-06-7;

Related CAS MeSH : 9041-93-4 (Bleomycin sulfate); M62KK37O40 (Bleomycin B2); 13M89UEA7W (Bleomycin A2);

MeSH annotation : a glycopeptide antineoplastic antibiotic;

Wikipedia link : https://en.wikipedia.org/wiki/Bleomycin;

Is substance : O;

Details

Origin ID

D001761;

UMLS CUI

C0005740;

ATC code(s)
- bleomycin [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Bleomycin A2 [NCIt concept]
- Bleomycin Sulfate [NCIt concept]
- Bleomycin sulfate [Substance BNPC]
- Bleomycin sulfate (substance) [SNOMED CT concept]
- bleomycin sulfate [SNOMED Notion]
CISMeF manual mappings
- Bleomycin adverse reaction (disorder) [SNOMED CT concept]
- Poisoning caused by bleomycin (disorder) [SNOMED CT concept]
Indexing information
- CEPP protocol [MeSH Supplementary Concept]
- bleomycin N-acetyltransferase [MeSH Supplementary Concept]
Pharmacological action(s)
- antibiotics, antineoplastic [MeSH Descriptor]
Record concept(s)
- BLEO-cell [MeSH concept]
- blenoxane [MeSH concept]
- bleolem [MeSH concept]
- bleomicina [MeSH concept]
- bleomycin [MeSH concept]
- bleomycin A2 [MeSH concept]
- bleomycin B2 [MeSH concept]
- bleomycin sulfate [MeSH concept]
- bleomycinum mack [MeSH concept]
- bléomycine bellon [MeSH concept]
Related MeSH Supplementary Concept(s)
- (N-(2-((4-((2-((4-(9-acridinylamino)phenyl)amino)-2-oxoethyl)amino)-4-oxobutyl)amino)-1-(1H-imidazol-4-ylmethyl)-1-oxoethyl)-6-(((-2-aminoethyl)amino)methyl)-2-pyridinecarboxamidato) iron(1+) [MeSH Supplementary Concept]
- 6'-deoxy-bleomycin Z [MeSH Supplementary Concept]
- A-VBM-FH6 protocol [MeSH Supplementary Concept]
- AAABC protocol [MeSH Supplementary Concept]
- ABDIC protocol [MeSH Supplementary Concept]
- ABEP protocol 2 [MeSH Supplementary Concept]
- ABLE protocol [MeSH Supplementary Concept]
- ABOD protocol [MeSH Supplementary Concept]
- ABP protocol 1 [MeSH Supplementary Concept]
- ABP protocol 2 [MeSH Supplementary Concept]
- ABV-ADV protocol [MeSH Supplementary Concept]
- ABVD protocol [MeSH Supplementary Concept]
- ABVDP protocol [MeSH Supplementary Concept]
- ABVG protocol [MeSH Supplementary Concept]
- ACOB regimen [MeSH Supplementary Concept]
- ACVB protocol [MeSH Supplementary Concept]
- AVBP protocol [MeSH Supplementary Concept]
- B-CAVe protocol [MeSH Supplementary Concept]
- B-DOPA protocol [MeSH Supplementary Concept]
- BACOD protocol [MeSH Supplementary Concept]
- BACOD-VP16 protocol [MeSH Supplementary Concept]
- BACON protocol [MeSH Supplementary Concept]
- BAP protocol 2 [MeSH Supplementary Concept]
- BAP regimen [MeSH Supplementary Concept]
- BAPP protocol [MeSH Supplementary Concept]
- BBVDD protocol [MeSH Supplementary Concept]
- BCD protocol [MeSH Supplementary Concept]
- BCMV protocol [MeSH Supplementary Concept]
- BCPE protocol [MeSH Supplementary Concept]
- BEACOPP protocol [MeSH Supplementary Concept]
- BECALM protocol [MeSH Supplementary Concept]
- BELD protocol [MeSH Supplementary Concept]
- BEMOP-CA protocol [MeSH Supplementary Concept]
- BEMP protocol [MeSH Supplementary Concept]
- BEMP protocol 2 [MeSH Supplementary Concept]
- BEP protocol [MeSH Supplementary Concept]
- BEPV protocol [MeSH Supplementary Concept]
- BIC protocol [MeSH Supplementary Concept]
- BIP protocol [MeSH Supplementary Concept]
- BLEDTA [MeSH Supplementary Concept]
- BLM-M protocol [MeSH Supplementary Concept]
- BMC protocol [MeSH Supplementary Concept]
- BMFt protocol [MeSH Supplementary Concept]
- BOAP protocol [MeSH Supplementary Concept]
- BOLD protocol [MeSH Supplementary Concept]
- BOM regimen [MeSH Supplementary Concept]
- BOMM protocol [MeSH Supplementary Concept]
- BOMP protocol [MeSH Supplementary Concept]
- BOP-CISCA-POMB-ACE regimen [MeSH Supplementary Concept]
- BOVAPEC protocol [MeSH Supplementary Concept]
- BV protocol [MeSH Supplementary Concept]
- BV-CAP protocol [MeSH Supplementary Concept]
- BVMM protocol [MeSH Supplementary Concept]
- BVMP regimen [MeSH Supplementary Concept]
- BVP protocol [MeSH Supplementary Concept]
- CAB protocol [MeSH Supplementary Concept]
- CAMBO-VIP protocol [MeSH Supplementary Concept]
- CAPABLE protocol [MeSH Supplementary Concept]
- CAVB protocol [MeSH Supplementary Concept]
- CBC protocol [MeSH Supplementary Concept]
- CBVD protocol [MeSH Supplementary Concept]
- CBVPM protocol [MeSH Supplementary Concept]
- CEBA combination [MeSH Supplementary Concept]
- CEOP-B protocol [MeSH Supplementary Concept]
- CEOP-MB protocol [MeSH Supplementary Concept]
- CEVBP protocol [MeSH Supplementary Concept]
- CFB protocol [MeSH Supplementary Concept]
- CHOP-B protocol [MeSH Supplementary Concept]
- CHV-mP-VB protocol [MeSH Supplementary Concept]
- CHVmP-VB protocol [MeSH Supplementary Concept]
- CIOP-Bleo protocol [MeSH Supplementary Concept]
- CISCA(II)-VB(IV) protocol [MeSH Supplementary Concept]
- CMB protocol [MeSH Supplementary Concept]
- CMF-B protocol [MeSH Supplementary Concept]
- COB protocol [MeSH Supplementary Concept]
- COBDP regimen [MeSH Supplementary Concept]
- CODBLAM IV protocol [MeSH Supplementary Concept]
- COFB protocol [MeSH Supplementary Concept]
- COMB protocol [MeSH Supplementary Concept]
- CONB-A protocol [MeSH Supplementary Concept]
- COP-B protocol [MeSH Supplementary Concept]
- COP-BLAM protocol [MeSH Supplementary Concept]
- COPEP protocol [MeSH Supplementary Concept]
- COPP-ABVD protocol [MeSH Supplementary Concept]
- CVAP-B protocol [MeSH Supplementary Concept]
- CVB protocol [MeSH Supplementary Concept]
- CVPPABO protocol [MeSH Supplementary Concept]
- CisEBP protocol [MeSH Supplementary Concept]
- DBVCy protocol [MeSH Supplementary Concept]
- DD1 protocol [MeSH Supplementary Concept]
- DDP-BLM protocol [MeSH Supplementary Concept]
- DEB-M protocol [MeSH Supplementary Concept]
- DOP protocol [MeSH Supplementary Concept]
- Dexa-PAMB protocol [MeSH Supplementary Concept]
- EBV protocol [MeSH Supplementary Concept]
- EBVD protocol [MeSH Supplementary Concept]
- EBVP protocol [MeSH Supplementary Concept]
- ECBC protocol [MeSH Supplementary Concept]
- EMB protocol [MeSH Supplementary Concept]
- EP-OMB protocol [MeSH Supplementary Concept]
- EpPt-OMB protocol [MeSH Supplementary Concept]
- HM 91 protocol [MeSH Supplementary Concept]
- HOAP-Bleo protocol [MeSH Supplementary Concept]
- HOPE-Bleo protocol [MeSH Supplementary Concept]
- JEB protocol [MeSH Supplementary Concept]
- LBCMVD-56 protocol [MeSH Supplementary Concept]
- LNH 84 protocol [MeSH Supplementary Concept]
- LNH 87 protocol [MeSH Supplementary Concept]
- LNH-80 regimen [MeSH Supplementary Concept]
- LNH87-2 protocol [MeSH Supplementary Concept]
- M-BACOD protocol [MeSH Supplementary Concept]
- M-BACOP protocol [MeSH Supplementary Concept]
- M-BACOS protocol [MeSH Supplementary Concept]
- M-BNCOD protocol [MeSH Supplementary Concept]
- MAB protocol [MeSH Supplementary Concept]
- MABOP protocol [MeSH Supplementary Concept]
- MACOP-B protocol [MeSH Supplementary Concept]
- MACOP-B regimen [MeSH Supplementary Concept]
- MBD protocol [MeSH Supplementary Concept]
- MINE-BOP protocol [MeSH Supplementary Concept]
- ML-Y1 protocol [MeSH Supplementary Concept]
- MNCOP-B protocol [MeSH Supplementary Concept]
- MOP-BAP protocol [MeSH Supplementary Concept]
- MOPP-ABV protocol [MeSH Supplementary Concept]
- MOPP-Bleo protocol [MeSH Supplementary Concept]
- MOPPEBVCAD protocol [MeSH Supplementary Concept]
- MVP-CAB protocol [MeSH Supplementary Concept]
- MVPP-Bleo protocol [MeSH Supplementary Concept]
- NC 0604 [MeSH Supplementary Concept]
- NCVB protocol [MeSH Supplementary Concept]
- NEO-MACOP-B protocol [MeSH Supplementary Concept]
- OAP-Bleo protocol [MeSH Supplementary Concept]
- P-COMM-B protocol [MeSH Supplementary Concept]
- P-VEBEC protocol [MeSH Supplementary Concept]
- PAB-CAP protocol [MeSH Supplementary Concept]
- PABlOE protocol [MeSH Supplementary Concept]
- PACE-BOM protocol [MeSH Supplementary Concept]
- PACEBO protocol [MeSH Supplementary Concept]
- PBMF protocol [MeSH Supplementary Concept]
- PBML protocol [MeSH Supplementary Concept]
- PD protocol [MeSH Supplementary Concept]
- PEV-B protocol [MeSH Supplementary Concept]
- PMitCEBO protocol [MeSH Supplementary Concept]
- POEM-Bleo protocol [MeSH Supplementary Concept]
- POMB-ACE protocol [MeSH Supplementary Concept]
- POMB-ACE regimen [MeSH Supplementary Concept]
- POMB-ACE-PAV regimen [MeSH Supplementary Concept]
- PROMACE-CytaBOM protocol [MeSH Supplementary Concept]
- PVB protocol [MeSH Supplementary Concept]
- PVeBV protocol [MeSH Supplementary Concept]
- Price-Hill protocol [MeSH Supplementary Concept]
- ProMECE-CytaBOM protocol [MeSH Supplementary Concept]
- SCAB protocol [MeSH Supplementary Concept]
- SF-1771 substance [MeSH Supplementary Concept]
- SF-1961 [MeSH Supplementary Concept]
- T-6 protocol [MeSH Supplementary Concept]
- T10 A protocol [MeSH Supplementary Concept]
- T7 protocol [MeSH Supplementary Concept]
- TBV protocol [MeSH Supplementary Concept]
- THP-COPBLM regimen [MeSH Supplementary Concept]
- VAB II protocol [MeSH Supplementary Concept]
- VAB protocol [MeSH Supplementary Concept]
- VAB-6 regimen [MeSH Supplementary Concept]
- VAB-III protocol [MeSH Supplementary Concept]
- VAB-IV protocol [MeSH Supplementary Concept]
- VABCD protocol [MeSH Supplementary Concept]
- VABE protocol [MeSH Supplementary Concept]
- VACO-B protocol [MeSH Supplementary Concept]
- VACOP-B protocol [MeSH Supplementary Concept]
- VAPEC-B protocol [MeSH Supplementary Concept]
- VBA protocol [MeSH Supplementary Concept]
- VBCMF protocol [MeSH Supplementary Concept]
- VBM protocol [MeSH Supplementary Concept]
- VBM protocol 2 [MeSH Supplementary Concept]
- VBMF protocol [MeSH Supplementary Concept]
- VBVP protocol [MeSH Supplementary Concept]
- VEBEP regimen [MeSH Supplementary Concept]
- VECABOP protocol [MeSH Supplementary Concept]
- VEPA-B protocol [MeSH Supplementary Concept]
- VICOP-B protocol [MeSH Supplementary Concept]
- VIM-Bleo protocol [MeSH Supplementary Concept]
- VIMB protocol [MeSH Supplementary Concept]
- VIP protocol 1 [MeSH Supplementary Concept]
- VIP-B protocol [MeSH Supplementary Concept]
- VIP-VB protocol [MeSH Supplementary Concept]
- VIPP-BM protocol [MeSH Supplementary Concept]
- VMBP protocol [MeSH Supplementary Concept]
- VNCOP-B protocol [MeSH Supplementary Concept]
- VP-BBML protocol [MeSH Supplementary Concept]
- VPCBAE protocol [MeSH Supplementary Concept]
- acetylbleomycin A2 [MeSH Supplementary Concept]
- aminopropylmethylpropyl-bleomycin [MeSH Supplementary Concept]
- antibiotic 1588 [MeSH Supplementary Concept]
- bleomycetin [MeSH Supplementary Concept]
- bleomycin A5 glycoconjugate [MeSH Supplementary Concept]
- bleomycin A5-pd(CCAAACA) [MeSH Supplementary Concept]
- bleomycin A6 [MeSH Supplementary Concept]
- bleomycin BAPP [MeSH Supplementary Concept]
- bleomycin-immunoglobulin G conjugate [MeSH Supplementary Concept]
- bleomycin-mannan conjugate [MeSH Supplementary Concept]
- bleomycin-vanadium(IV) complex [MeSH Supplementary Concept]
- bleomycinic acid [MeSH Supplementary Concept]
- boningmycin [MeSH Supplementary Concept]
- cadmium bleomycin [MeSH Supplementary Concept]
- cleomycin B2 [MeSH Supplementary Concept]
- cobalt bleomycin [MeSH Supplementary Concept]
- concanavalin A conjugated bleomycin [MeSH Supplementary Concept]
- copper bleomycin [MeSH Supplementary Concept]
- cugamycin [MeSH Supplementary Concept]
- deglycobleomycin [MeSH Supplementary Concept]
- depyruvamide bleomycin [MeSH Supplementary Concept]
- fluoromycin [MeSH Supplementary Concept]
- idoxuridine-bleomycin protocol [MeSH Supplementary Concept]
- indium-bleomycin [MeSH Supplementary Concept]
- iron bleomycin [MeSH Supplementary Concept]
- liblomycin [MeSH Supplementary Concept]
- m-BECOD protocol [MeSH Supplementary Concept]
- m-BOP protocol [MeSH Supplementary Concept]
- m-M-BACOD protocol [MeSH Supplementary Concept]
- manganese bleomycin [MeSH Supplementary Concept]
- mito-MBD protocol [MeSH Supplementary Concept]
- nickel bleomycin [MeSH Supplementary Concept]
- nitrosyl iron(II) bleomycin [MeSH Supplementary Concept]
- pentaammineruthenium(III)-bleomycin complex [MeSH Supplementary Concept]
- peroxycobalt bleomycin [MeSH Supplementary Concept]
- phleomycin D1 [MeSH Supplementary Concept]
- platomycin [MeSH Supplementary Concept]
- rosen's T-10 protocol [MeSH Supplementary Concept]
- ruthenium(II)-bleomycin [MeSH Supplementary Concept]
- stanford V protocol [MeSH Supplementary Concept]
- talisomycin [MeSH Supplementary Concept]
- tallysomycin H-1 [MeSH Supplementary Concept]
- technetium tc 99m bleomycin [MeSH Supplementary Concept]
- technetium tc 99m pingyangmycin [MeSH Supplementary Concept]
- victomycin [MeSH Supplementary Concept]
- zeocin [MeSH Supplementary Concept]
- zhengguangmycin [MeSH Supplementary Concept]
- zinc bleomycin [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Bleomycin [ACR pathology]
- Product containing bleomycin (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Antibiotic [UMLS semantic type]
UMLS correspondences (same concept)
- Bleomycin [ICD-11 Extension code]
- Bleomycin [NCIt concept]
- Bleomycin (substance) [SNOMED CT concept]
- Bleomycin Antibiotic [NCIt concept]
- Product containing bleomycin (medicinal product) [SNOMED CT concept]
- bleomycin [ATC Code]
- bleomycin [SNOMED Notion]
Validated automatic mappings to NTBT
- Bleomycin Antibiotic [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients